Standout Papers

CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia 2022 2026 2023 202496
  1. CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia (2022)
    Bin Fu, Jiaoyang Liao et al. Nature Medicine

Immediate Impact

37 standout
Sub-graph 1 of 15

Citing Papers

Noncoding RNAs in sepsis-associated acute liver injury: Roles, mechanisms, and therapeutic applications
2025 Standout
Invasion and metastasis in cancer: molecular insights and therapeutic targets
2025 Standout
2 intermediate papers

Works of Bin Fu being referenced

CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia
2022 Standout
Novel circular RNA 2960 contributes to secondary damage of spinal cord injury by sponging miRNA ‐124
2020

Author Peers

Author Last Decade Papers Cites
Bin Fu 79 156 62 70 30 336
Ling Ma 56 179 14 82 11 396
XH Wang 139 119 106 44 18 354
Xiaoping Wei 22 126 21 96 22 394
K.H. Ramesh 49 153 38 50 38 370
Sparkes Rs 121 140 72 42 30 377
C. Man 38 199 36 14 16 349
Rolando García 86 107 86 74 45 400
Tianxiang Hu 77 234 58 43 36 350
Mariagrazia Zucca 12 95 30 54 22 384
Julia W. Grimstead 43 252 31 42 20 407

All Works

Loading papers...

Rankless by CCL
2026